MAPT and Alzheimer disease: Increases in the levels of phosphorylated Tau protein (pTau), as well as an increase in the relative abundance of Aβ42 fragments, are hallmarks of AD pathology in the brain, and similar phenotypes have also been observed in the retinas of AD patients39,40.